FDA Dermal Fillers Panel Calls For Larger Clinical Trials Focused On Safety
This article was originally published in The Gray Sheet
Executive SummaryFDA's General and Plastic Surgery Devices advisory panel called for larger, safety-focused pre-market clinical trials for future aesthetic facial dermal filler products
You may also be interested in...
With positive data from two Phase III trials, Incyte hopes to file an NDA this year for topical Jakafi in mild-to-moderate AD.